Alessandro Gronchi

Research interests

Publications

• Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

  Cancer · 2021 · https://doi.org/10.1002/cncr.33618

• Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.08.1995

• Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

  ESMO Open · 2021 · https://doi.org/10.1016/j.esmoop.2021.100170

• Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

  Annals of Surgical Oncology · 2021 · https://doi.org/10.1245/s10434-021-09654-z

• Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.09.005

• Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.07.006

• Delaying surgery for patients with a previous SARS-CoV-2 infection

  British journal of surgery · 2020 · https://doi.org/10.1002/bjs.12050

• The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

  European Journal of Cancer · 2020 · 10.1016/j.ejca.2019.11.013

• NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30326-2

• Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

  JAMA Oncology · 2018 · https://doi.org/10.1001/jamaoncol.2017.4996

• Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy096

• Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy310

• Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy095

• Corrections to “Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy321

• Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx054

• An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)

  Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx323

• Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

  The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)00010-3

• Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment

  Annals of Surgical Oncology · 2009 · https://doi.org/10.1245/s10434-009-0586-2

• Aggressive Surgical Policies in a Retrospectively Reviewed Single-Institution Case Series of Retroperitoneal Soft Tissue Sarcoma Patients

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.17.8871

• Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

  The Lancet Oncology · 2007 · https://doi.org/10.1016/s1470-2045(07)70175-4

• NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines

  Journal of the National Comprehensive Cancer Network · 2007 · https://doi.org/10.6004/jnccn.2007.2002

• Malignant peripheral nerve sheath tumors

  Cancer · 2006 · https://doi.org/10.1002/cncr.22098

• Molecular and Biochemical Analyses of Platelet-Derived Growth Factor Receptor (PDGFR) B, PDGFRA, and KIT Receptors in Chordomas

  Clinical Cancer Research · 2006 · https://doi.org/10.1158/1078-0432.ccr-06-1584

• Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

  Annals of Oncology · 2005 · https://doi.org/10.1093/annonc/mdi127

• Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution

  Journal of Clinical Oncology · 2003 · https://doi.org/10.1200/jco.2003.05.150

Current projects

No projects listed.